San Francisco Sentry Investment Group’s 10x Genomics TXG Stock Holding History

San Francisco Sentry Investment Group’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$42K	Sell	214 -41	-16%	-$7.42K	0.02%	390
2021 Q1	$46K	Buy	255 +27	+12%	+$4.66K	0.02%	389
2020 Q4	$32K	Sell	228 -1	-0.4%	-$145	0.02%	410
2020 Q3	$29K	Buy	229 +76	+50%	+$7.98K	0.01%	394
2020 Q2	$14K	Hold	153	–	–	0.01%	460
2020 Q1	$10K	Buy	+153	New	+$11.9K	0.01%	479

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

MCAV

Meritech Capital Associates V Palo Alto, California $141M AUM 15.44% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

San Francisco Sentry Investment Group's TXG Position: Q2 2021 in Review

San Francisco Sentry Investment Group reduced its 10x Genomics (TXG) stake by 16% in Q2 2021, selling an estimated $7.42K and leaving 214 shares worth $42K. The position accounts for 0.02% of the portfolio, ranked #390.

San Francisco Sentry Investment Group first reported a position in TXG in Q1 2020 and has held it in 6 quarters since. The position peaked at $46K in Q1 2021. 340 funds tracked by Wall St. Rank hold TXG as of Q2 2021.

San Francisco Sentry Investment Group held 214 shares of 10x Genomics worth $42K as of Q2 2021.
San Francisco Sentry Investment Group sold 41 10x Genomics shares in Q2 2021, an estimated $7.42K.
10x Genomics made up 0.02% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #390 holding.
San Francisco Sentry Investment Group first reported a position in 10x Genomics in Q1 2020 and has held it in 6 quarters since.
San Francisco Sentry Investment Group's 10x Genomics position peaked at $46K in Q1 2021.
340 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2021.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.